ArticleScientific reports2025
Antimicrobial resistance surveillance of gram-negative bacteria among solid organ transplant recipients, a 4-year retrospective study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications.Pathogens (Basel, Switzerland) · 2026Review
- Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025.Frontiers in cellular and infection microbiology · 2026Article
- The species, distribution, resistance of donor-derived pathogens and their impact on solid organ transplant recipients.Frontiers in immunology · 2026Article
- Urinary Tract Infections and Bacterial Multidrug Resistance in Kidney Transplant Impact on Function and Graft Survival.Clinics and practice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial infections are among the major complications patients face after solid organ transplantation, resulting in substantial morbidity and mortality among them. Meanwhile, the incidence of antimicrobial resistance in gram-negative bacteria is concerning, for which establishing antibiotic stewardship programs would be essential, where an understanding of the resistance-susceptibility patterns can be detrimental. This study aims to give an understanding of this pattern in the gram-negative bacterial isolates in the past four years. In this retrospective four-year study, the resistance-susceptibility patterns of gram-negative pathogens isolated from blood, urine, sputum, wound drainage, abscess, synovial, pleural, ascitic, and cerebrospinal fluids of the adult and children patients undergoing solid organ transplantation at Shiraz Transplant Center, the biggest solid organ transplantation center of Asia, in 2020-2023. During the study follow-up period, 2075 GNB isolates were retrieved from the patients. The most frequent isolates were identified as E.coli with 765 (36.86%), Klebsiella with 684 (32.96%), Pseudomonas with 363 (17.49%), Acinetobacter with 134 (6.45%), Enterobacter with 87 (4.19%), Citrobacter with 40 (1.92%), and Stenotrophomonas maltophilia with 2 specimens (0.09%), from the highest to the lowest. Of the retrieved GNB isolates from the transplant patients, 1380 (66.50%) belonged to liver transplant recipients, 658 isolates (31.71%) belonged to kidney transplant recipients, and 23 isolates (1.10%) belonged to simultaneous kidney and pancreas transplant recipients. Carbapenem-resistant Enterobacterales, mainly carbapenem-resistant K. pneumoniae (CRKP) isolates, increased during follow-up periods. The findings of this study reveal an increasing pattern of resistance towards carbapenems in Enterobacterales, which is significant in liver transplant recipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.